Atluri Cardiovascular Research Lab
Our lab focuses on developing novel therapeutics for both acute and chronic heart failure. Using molecular and tissue engineering approaches that harness the power of myocardial regeneration, neovascularizaton, and optimization of myocyte function we address the problem of heart failure. Analysis is performed in both in both small and large animal models with the ultimate focus of rapid clinical translation of therapeutic strategies. We have worked with novel biomaterials to optimize therapeutic efficiency and provide minimally invasive delivery options.
Clinical investigation is focused on optimization of heart transplant, mechanical circulatory support, and minimally invasive and robotic cardiac surgical procedures.
In the News
Iyengar A, Weingarten N, Herbst DA, Helmers,... Ann Thorac Surg. 2021 July 31
Atluri Lab Events
2022 American Heart Association
--"Successful Targeting Of A Superoxide Dismutase-loaded Nanoparticle To Rat Cardiomyocytes" submitted by Dr. Alan D. Herbst
European Association For Cardio-Thoracic Surgery Annual Meeting
--"Outcomes of Patients with Chronic Kidney Disease in the Era of Heartmate 3."- Submitted by Dr. Alan D. Herbst
--"Prosthesis Choice in Dialysis Patients Undergoing Mitral Valve Replacement."- Submitted by Dr. Amit Iyengar
--"Heart-Kidney transplant versus Heart Transplant in the Obese."- Submitted by Dr. Noah Weingarten
--"The Effect of Obesity on Heart-Kidney Transplant Outcomes."- Submitted by Dr. Noah Weingarten
International Society For Heart And Lung Transplant
--"The Regional Impact of the 2018 United States Heart Allocation System Change."- Submitted by Dr. Amit Iyengar
--“Very Short Stature Predicts Morbidity and Mortality After Heart Transplant.”- Submitted by Dr. Noah Weingarten